BioWorld

Nov. 16, 2010

View Archived Issues

Primate Spinal Cord Recovery Greater than Rat Studies Show

Read More

'Stratified Medicine' Shatters Bio-Pharma Partnering Model

Read More

Stock Movers

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Specialty Pharma Firm AcelRx Joins IPO Queue: $86M Filing

AcelRx Pharmaceuticals Inc. joined the initial public offering (IPO) queue, filing to raise up to $86.25 million in its debut. (BioWorld Today) Read More

Cerulean Pushing Nano-based Pipeline via $24M Series C

Read More

AHA Roundup

Read More